COMPOSITES AND COMPOSITIONS FOR THERAPEUTIC USE AND METHODS OF MAKING AND USING THE SAME
    1.
    发明申请
    COMPOSITES AND COMPOSITIONS FOR THERAPEUTIC USE AND METHODS OF MAKING AND USING THE SAME 审中-公开
    用于治疗用途的复合材料和组合物及其制备和使用方法

    公开(公告)号:WO2017015150A1

    公开(公告)日:2017-01-26

    申请号:PCT/US2016/042613

    申请日:2016-07-15

    摘要: Disclosed herein are embodiments of composites and compositions that can be used for therapeutic applications in vivo and/or in vitro. The disclosed composites can comprise cores having magnetic nanoparticles, quantum dots, or combinations thereof and zwitterionic polymeric coatings that facilitate solubility and bioconjugation. The compositions disclosed herein can comprise the composites and one or more biomolecules, drugs, or combinations thereof. Also disclosed herein are methods of making the composites, composite components, and methods of making quantum dots for use in the composites.

    摘要翻译: 本文公开了可以在体内和/或体外用于治疗应用的复合物和组合物的实施方案。 所公开的复合材料可以包括具有磁性纳米颗粒,量子点或其组合的芯和促进溶解度和生物共轭的两性离子聚合物涂层。 本文公开的组合物可以包含复合材料和一种或多种生物分子,药物或其组合。 本文还公开了制备用于复合材料的复合材料,复合材料组分和制备量子点的方法的方法。

    세포의 지질막에서 유래된 나노소포체 및 이의 용도
    2.
    发明申请
    세포의 지질막에서 유래된 나노소포체 및 이의 용도 审中-公开
    从细胞膜衍生的纳米微粒及其用途

    公开(公告)号:WO2016133254A1

    公开(公告)日:2016-08-25

    申请号:PCT/KR2015/008801

    申请日:2015-08-24

    摘要: 본 발명은 세포의 지질막(cell membrane)에서 유래된 나노소포체(nanovesicles), 이의 제조방법, 상기 나노소포체를 이용한 약제학적 조성물, 및 진단 키트 등에 관한 것이다. 본 발명에 따른 세포 지질막 유래 나노소포체는 치료용 또는 진단용 물질 전달에 불필요한 세포 내 물질(유전 물질 및 세포 내 단백질)이 제거되어 잠재적 부작용을 없앨 수 있고, 세포 또는 조직 타겟팅이 가능하므로 목표한 세포 또는 조직에 주로 치료용 또는 진단용 물질을 전달하고 다른 곳에 치료용 또는 진단용 물질의 전달을 억제함으로써 약물 등 치료용 물질의 부작용을 줄여서 질병 치료 과정에서 환자의 고통과 불편을 줄일 수 있으며, 치료효능을 증가시킬 수 있다. 또한, 질병 치료용 또는 진단용 물질이 로딩된 본 발명의 세포 지질막 유래 나노소포체 및 그의 제조 방법은 in vitro 또는 in vivo 에서 치료 또는 진단용, 또는 실험용으로 사용될 수 있다.

    摘要翻译: 本发明涉及来自细胞膜的纳米囊,其制备方法,使用该纳米囊的药物组合物和诊断试剂盒。 根据本发明,由于可以从细胞膜衍生的纳米囊中除去不需要用于递送治疗或诊断材料的细胞内物质(遗传物质和细胞内蛋白质),并且由于细胞或组织靶向是可能的,因此可以去除潜在的副作用 ,治疗或诊断材料主要被递送到靶细胞或组织,并且防止治疗或诊断材料被递送到其他位置,从而减少诸如药物的治疗材料的副作用,使得患者的疼痛 在疾病治疗期间可以减轻不适,并且可以提高治疗效果。 此外,本发明的用于治疗或诊断疾病的材料的本发明的细胞膜衍生的纳米囊体及其制备方法可用于体外或体内治疗或诊断或实验。

    PHARMACEUTICAL FORMULATION HAVING REVERSE THERMAL GELATION PROPERTIES FOR LOCAL DELIVERY OF NANOPARTICLES
    3.
    发明申请
    PHARMACEUTICAL FORMULATION HAVING REVERSE THERMAL GELATION PROPERTIES FOR LOCAL DELIVERY OF NANOPARTICLES 审中-公开
    具有反向热凝性能的药物制剂,用于局部递送纳米颗粒

    公开(公告)号:WO2016087674A1

    公开(公告)日:2016-06-09

    申请号:PCT/EP2015/078741

    申请日:2015-12-06

    IPC分类号: A61K49/00 A61K41/00 A61K31/00

    摘要: The present invention refers to a pharmaceutical formulation for injection comprising fluorescent nanoparticles as in vivo diagnostics. The present invention relates to an injectable pharmaceutical formulation for human medicine and/or veterinary use, comprising 17% to 20% per weight of poloxamer 407 and 3% - 15% per weight of poloxamer 188, 0.10 nM to 10.0 μΜ fluorescent nanoparticles and water or an aqueous buffer, wherein the pharmaceutical formulation is liquid at 4°C - 32°C and forms a gel at about 37°C, their use as an in vivo marker and methods of their preparation. The inventive formulation is useful for local control and prevention of spreading/diffusion of nanoparticles, and thus allows full utilization of their quantum physics properties for example as a tool to enable surgical precision of tumor removal; even without tumor specific epitope binding antibodies.

    摘要翻译: 本发明涉及用于注射的药物制剂,其包含作为体内诊断的荧光纳米颗粒。 本发明涉及用于人类药物和/或兽医用途的可注射药物制剂,其包含17重量%至20重量%泊洛沙姆407和3重量%-15重量%泊洛沙姆188,10.1nM至10.0微米荧光纳米颗粒和水 或水性缓冲液,其中药物制剂在4℃至32℃下为液体,并在约37℃下形成凝胶,其用作体内标记物及其制备方法。 本发明的制剂可用于局部控制和防止纳米颗粒的扩散/扩散,因此允许充分利用其量子物理性质,例如作为使手术切除肿瘤精确度的工具; 即使没有肿瘤特异性表位结合抗体。

    PHOTOSENSITIVE AMINOACID-MONOMER LINKAGE AND BIOCONJUGATION APPLICATIONS IN LIFE SCIENCES AND BIOTECHNOLOGY
    9.
    发明申请
    PHOTOSENSITIVE AMINOACID-MONOMER LINKAGE AND BIOCONJUGATION APPLICATIONS IN LIFE SCIENCES AND BIOTECHNOLOGY 审中-公开
    生物科学和生物技术中的光敏氨基酸单体连接和生物化学应用

    公开(公告)号:WO2011070402A1

    公开(公告)日:2011-06-16

    申请号:PCT/IB2009/055707

    申请日:2009-12-11

    申请人: SAY, Ridvan

    IPC分类号: C07D209/20 C07D213/06

    摘要: This invention is related to preparation of photosensitive ruthenium based aminoacid monomers and oligomers, aminoacid monomer-protein cross- linking using photo sensitat ion and conjugation on micro and nano-structures by ruthenium-chelate based monomers. Its vast range biotechnolgy applications of multifunctional, biocompatible, stabilE and specific micro and nanobio-conjugates, which will stand-alone or simultaneously enable (i) both purification and determination, (ii) both targeting and imaging and theranostics and (iii) catalysis and determination. The construction and method of preparation is applicable to silica materials, superparamagnetic particles, QDs, CNTs, Ag/ Au nanoparticles and Au surfaces and polymeric materials. The photosensitive aminoacid monomer linkers can react via chemically and biocompatible to a lot of different micro and nano-surface and then to the protein when they act as a single-step cross-linking reaction using irradiation. The photosensitive conjugation based on click biochemistry can be carried out at mild conditions, independent of pH and temperature, without affecting conformation and function of protein.

    摘要翻译: 本发明涉及基于钌螯合物的单体制备感光钌基氨基酸单体和低聚物,使用光敏化剂的氨基酸单体 - 蛋白质交联和在微纳米结构上的缀合。 其广泛的多功能,生物相容性,稳定性和特异性微纳米偶联物的生物技术应用,其将独立或同时使得(i)纯化和测定,(ii)靶向和成像和分析和(iii)催化和 决心。 其制备方法适用于二氧化硅材料,超顺磁性颗粒,量子点,碳纳米管,Ag / Au纳米颗粒和Au表面和聚合材料。 光敏氨基酸单体接头可以通过化学和生物相容性反应到大量不同的微观和纳米表面,然后当它们作为使用照射的单步交联反应时,与蛋白反应。 基于点击生物化学的感光共轭可以在温和条件下进行,与pH和温度无关,不影响蛋白质的构象和功能。